Stem cell gene therapy - search results

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group provides a comprehensive overview of sensory processing disorder (SPD) in children today Children with sensory processing disorder or dysfunction (SPD) are characterised by the occurrence of inward information in very atypical, diverting modes. Energising diagnosis and treatment through multi-sensory behaviour and activity...

Cecilia Van Cauwenberghe, Vandana Iyer and Bhargav Rajan from Frost & Sullivan examine of how nanotechnology helps spot early stage cancer

Ivan Stamenkovic, professor of experimental pathology at the University of Lausanne underlines research taking place around cancer progression Cancer progression, meaning the evolution of localised tumour growth to an invasion of adjacent tissue and dissemination to distant organs is a complex process that is intimately related to interactions between tumour...

Research professor Prof Colin J Suckling OBE DSc FRSE discusses his engagement with medicinal chemistry and chemical biology

Associate professor at CHU Clermont-Ferrand, Université Clermont Auvergne, Matthieu Jabaudon highlights the hopeful future for ARDS

CEO of the BioIndustry Association (BIA), Steve Bates explores how the UK government is supporting biotech in order to create innovative medicines

Jukka Putaala from the European Stroke Organisation outlines the effects of stroke in young people compared to stroke in the older generation

Biomedical research crosses borders of disciplines to help shape new imaging approaches, as scientists from Technical University of Munich explain

Director of Research Support Dr Ana M Terres notes the importance of health research and the strides being achieved by researchers at Dublin City University

University of Perugia’s Ursula Grohmann and Antonio Macchiarulo share the work of the DIDO project in understanding cancer and autoimmune disease therapies

Jennifer Simpson of the Huntington’s disease Society of America highlights the disease and how there is still a long way to go before it can be truly understood

University of Oulu’s Professor Riitta Veijola discusses the impact of Type 1 diabetes on society and the challenges associated with tackling the disease

Dr. Lisa Halvorson, U.S. National Institutes of Health discusses the importance of gynaecologic research to develop new treatments and keep women healthy

By providing the infrastructure to support drug discovery, the IMI is accelerating access to innovative medicines, as the EFPIA highlights here Innovation is the lifeblood of the pharmaceutical industry, providing us with the potential to cross new therapeutic frontiers to bring novel medicines to market that benefit patients and deliver...

Dr Ramón Cacabelos, President of EuroEspes Biomedical Research Center, highlights the potential benefits of novel nutraceuticals including ProteoLipins Pharmacotherapy is a fundamental cornerstone in the global fight against disease worldwide. The value of drug production has grown four times more rapidly than the world’s income. High-income countries dominate in world...

Jo Vandesompele, Chief Scientific Officer at Biogazelle, outlines how non-coding RNA research for cancer can help develop a more targeted treatment approach  DNA is the hereditary code that is passed on from parents to their children. Every cell inside our body has the same code that contains the blueprint of...

Rachel Clark, Health Promotion Manager, at World Cancer Research Fund, sheds light on breast cancer and how to reduce the risks of developing the disease. Breast cancer is the most common cancer in women in the UK. In fact, 1 in 8 women will develop the disease at some stage...

Professor Colin J Suckling, Research Professor of Chemistry at the Department of Pure & Applied Chemistry, University of Strathclyde looks at how the recent EU Referendum could impact his institution and research. Like many British academics, the result of the recent referendum on the UK’s place in Europe was a...

Terra G. Arnason and Troy A.A. Harkness from the Departments of Medicine, and Anatomy and Cell Biology at the University of Saskatchewan detail current strategies to prevent or reverse multiple drug resistant malignancy… Multiple drug resistance (MDR) can be present from the outset (inherent) or develop (acquired) in response to...

Prof David Nutt, European Brain Council on the economic impact of poor brain health & how they are calling for new thinking towards how it is treated